|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:931-938
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Divisions of Cardiac Surgerya and Cardiology,e Children's Hospital and Regional Medical Center, Seattle; the Departments of Pathologyb and Surgery,d University of Washington, Seattle, Wash; and the Department of Cardiovascular Surgery,c The Children's Hospital, Bratislava, Slovakia.
Received for publication Aug 17, 1998. Revisions requested Oct 30, 1998. Revisions received Dec 29, 1998. Accepted for publication Jan 13, 1999. Address for reprints: Brian W. Duncan, MD, Division of Cardiac Surgery, Children's Hospital and Regional Medical Center, 4800 Sand Point Way, NE, PO Box 5371/CM-03, Seattle, WA 98105.
| Abstract |
|---|
|
|
|---|
-smooth muscle actin, weak staining for the endothelial marker CD31 (cluster of differentiation, PECAM-1), and negative staining for proliferating cell nuclear antigen. Electron microscopy revealed endothelial irregularity, a disorganized basement membrane, and increased numbers of collagen and actin filaments beneath the endothelium.| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
Histology and microvessel density
Lung biopsy specimens were obtained during the most recent operation in both patients to aid in determining the cause of progressive hypoxemia. Surgical consent was obtained in each case. A single biopsy specimen was obtained from the periphery of the lingula in each patient without an effort to obtain tissue from the regions of the lung that were most severely affected according to the angiograms. All studies were performed on the surgical specimens from these patients. Lung tissue was also examined from age-matched controls, archived specimens obtained from children who did not have cardiac disease. One specimen came from an autopsy of a child who died of viral encephalomyelitis. The other specimen was from a peripheral lung biopsy performed in a child with mild pulmonary insufficiency; the tissue demonstrated no diagnostic abnormality. Lung biopsy tissue had been fixed in Methacarn (60% methanol, 30% chloroform, 10% acetic acid) or 10% neutral buffered formalin, dehydrated in graded alcohols, xylene infiltrated, and embedded in paraffin. Serial sections were cut 5-µm thick, cleaned of paraffin, and rehydrated in xylenes and graded alcohols. Sections were stained for routine histologic evaluation with hematoxylin and eosin or Movat's pentachrome. Microvessel density was determined by counting the number of blood vessels in 10 randomly selected high-power fields (200x) in histologic sections stained with Movat's pentachrome by means of a computerized system
5 (Bioscan Optimas Image Analysis, Bothell, Wash) and expressed as the number of blood vessels per high-power field. This analysis was performed and the results were compared between the patients having pulmonary AV malformations and the archived age-matched controls.
Immunohistochemistry
Histologic sections were pretreated as necessary with protease (0.01% weight/volume) and sodium citrate (10 µmol/L), and endogenous peroxidase was quenched with hydrogen peroxide (3% volume/volume). Nonspecific binding sites were blocked with nonfat dry milk (5% weight/volume) and/or normal horse serum (50 µL/10 mL) before addition of primary antibodies. Primary antibodies used were as follows: proliferating cell nuclear antigen (PCNA), CD31 (cluster of differentiation, PECAM-1), collagen type IV (all from DAKO, Carpinteria, Calif), and a-smooth muscle actin (Boehringer-Manheim, Indianapolis, Ind). Primary antibodies were diluted in phosphate-buffered saline solution and applied to the sections for 1 hour. Secondary antibodies (horse antimouse or horse antirabbit [both from DAKO] depending on the primary antibody) were diluted 1:500, applied for 30 minutes, and washed in phosphate-buffered saline solution. Avidin-biotin complex (Vector, Burlingame, Calif) was applied for 30 minutes, washed in phosphate-buffered saline solution, and pretreated with Trisma:HCl buffer (Sigma Chemical Co, St Louis, Mo). Slides were then immersed in chromagen complex (diaminobenzidine, 5 µg), 3% hydrogen peroxide (750 mL), and Trisma:HCl buffer (175 mL) and counterstained with methyl green. Appropriate positive and negative controls were examined to determine that staining was specific.
Electron microscopy
Tissue was fixed for 2 hours at 4°C in Karnovsky's fixative (4% formaldehyde and 5% glutaraldehyde), postfixed in 2% osmium tetroxide, and embedded in Epon fixative. Sections 1-µm thick were stained with toluidine blue. Thin sections were prepared and stained with uranyl acetate and lead citrate. These sections were photographed with a JEOL 100B transmission electron microscope (JEOL USA, Peabody, Mass).
Statistical analysis
The average microvessel density for the 10 high-power microscopic fields was determined for both patients and their age-matched controls. The mean of the differences of the average microvessel density for the patients with pulmonary AV malformations and their age-matched controls was compared by means of the paired t test.
| Results |
|---|
|
|
|---|
|
|
-smooth muscle actin in most pulmonary AV malformations, including small chain-like vessels (not shown).
|
|
| Discussion |
|---|
|
|
|---|
The present study attempts to provide a detailed analysis of the histologic and ultrastructural features of pulmonary AV malformations that form in children with some forms of cyanotic congenital heart disease. We were successful in identifying the microscopic lesion associated with the physiologic abnormality of pulmonary AV malformations, finding greatly increased numbers of vessels with 2 different morphologic types—lakes of dilated, thin-walled vessels and chains of clustered, smaller vessels. This was a diffuse process extending into regions of the lung periphery that did not appear to be significantly involved on preoperative angiography. The demonstration of branches from the precapillary arterioles into these thin-walled vessels may represent the histologic correlate of the right-to-left shunt that these children demonstrate. Blood leaving the precapillary arterioles at this level and returning to the heart would presumably remain desaturated and not be available for gas exchange. The determination of microvessel density, which has proven to have prognostic significance in tumor specimens,
7 may have some clinical utility in grading the severity of pulmonary AV malformations in lung biopsy tissue. However, the microvessel density results have broader implications in terms of the angiogenic potential of this tissue. In oncologic studies, increased microvessel density is usually associated with accelerated angiogenesis resulting in an increased proliferative state of the tumor. These results suggest that pulmonary AV malformations that develop after cavopulmonary anastomosis might be similar to other conditions that are due to abnormally increased angiogenesis.
Pulmonary AV malformations in these patients, however, show no evidence of excess proliferative activity by immunohistologic techniques. The specific staining patterns for endothelial and proliferation markers were unique when compared with patterns in other lesions that demonstrate intense vascular proliferation, such as soft tissue hemangiomas.
8 Proliferating phase hemangiomas are angiogenically active neoplasms that are composed of vast numbers of small blood vessels with a high proliferative activity. Proliferating hemangiomas are PCNA positive and demonstrate positive staining for CD31. The pulmonary AV malformations were PCNA negative and stained only faintly for CD31 in a minority of the vessels, with many of the vessels demonstrating no CD31 staining. PCNA is a nuclear protein that is associated with the control of cell cycle progression and is expressed in tissues that are rapidly proliferating.
9 Tissues that demonstrate active angiogenesis usually contain endothelial cells that stain positively for PCNA. These results suggest that vascular expansion has occurred in pulmonary AV malformations without the exuberant cellular proliferation that might be expected. A possible explanation is that endothelial cell spreading and migration may be responsible for "new" blood vessel formation in these lesions. Alternatively, the absence of excessive cellular proliferation may signify that pulmonary AV malformations arise from the distention and dilatation of previously existing vascular channels that enlarge as collateral vessels in response to pressure gradients between the SVC and the IVC (after a Glenn procedure) or the mesenteric venous circulation (after a Kawashima procedure).
CD31 is a platelet and endothelial adhesion molecule that is present at intercellular junctions between endothelial cells.
10 The diminished CD31 staining in the pulmonary AV malformations is consistent with the discontinuity of the endothelium visualized by electron microscopic studies; alternatively, it may reflect down-regulation of this endothelial surface marker. Decreased intercellular junctions between the endothelial cells might have resulted in the edema that could be visualized histologically (Fig. 2,
A) and may have etiologic implications regarding capillary leak and pleural effusions, which these children often have after surgery. Another interesting observation from the electron microscopic results was the demonstration of disordered collagen fibrils and disruption of the basement membrane, as well as endothelial irregularity. Another possible explanation for these electron microscopic changes could be due to a component of injury response with collagen disruption and prominent interstitial edema. The source of this injury is not clear but could be a host response to a number of physiologic alterations that these children experience, such as chronic hypoxia or nonpulsatile pulmonary blood flow.
The rarity of this condition is reflected in the fact that only 2 patients have undergone this in-depth histologic analysis. As these techniques are applied to larger numbers of patients, their more general applicability for this lesion can be determined. The role of blood vessel proliferation versus vascular dilatation has been raised as an area of question that has not been definitively established by this work. Finally, the role of the liver in the development of these lesions has not been addressed by these techniques. Ideally, however, this work will serve as a preliminary inquiry that will lead to future studies that further our understanding of the nature and etiology of this condition.
| Summary |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. S. Tipps, M. Mumtaz, P. Leahy, and B. W. Duncan Gene array analysis of a rat model of pulmonary arteriovenous malformations after superior cavopulmonary anastomosis. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Urcelay, A. J. Borzutzky, P. A. Becker, and M. E. Castillo Nitric Oxide in Pulmonary Arteriovenous Malformations and Fontan Procedure Ann. Thorac. Surg., July 1, 2005; 80(1): 338 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Georghiou, E. Birk, and B. A. Vidne Is there a reversal of pulmonary arteriovenous malformation after redirection of anomalous hepatic venous flow to the lungs? Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 227 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mumtaz, C. H. Fraga, C. M. Nicholls, S. Desai, N. Vasilyev, R. Joshi, R. B.B. Mee, and B. W. Duncan Increased expression of vascular endothelial growth factor messenger RNA in lungs of rats after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 209 - 210. [Full Text] [PDF] |
||||
![]() |
A. Ikai, R. K. Riemer, X. Ma, O. Reinhartz, F. L. Hanley, and V. M. Reddy Pulmonary expression of the hepatocyte growth factor receptor c-Met shifts from medial to intimal layer after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1442 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ikai, M. Shirai, K. Nishimura, T. Ikeda, T. Kameyama, K. Ueyama, and M. Komeda Hypoxic pulmonary vasoconstriction disappears in a rabbit model of cavopulmonary shunt J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1450 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Friehs and P. J. del Nido Invited commentary Ann. Thorac. Surg., February 1, 2004; 77(2): 463 - 463. [Full Text] [PDF] |
||||
![]() |
A. Dodge-Khatami, N. Sreeram, B.A.J.M. de Mol, and G.B.W.E. Bennink Systemic plasma vascular endothelial growth factor levels as a marker for increased angiogenesis during the single ventricle surgical pathway Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 458 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Duncan and S. Desai Pulmonary arteriovenous malformations after cavopulmonary anastomosis Ann. Thorac. Surg., November 1, 2003; 76(5): 1759 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ono, Y. Sawa, K. Matsumoto, T. Nakamura, Y. Kaneda, and H. Matsuda In Vivo Gene Transfection With Hepatocyte Growth Factor via the Pulmonary Artery Induces Angiogenesis in the Rat Lung Circulation, September 24, 2002; 106(12_suppl_1): I-264 - I-269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Malhotra, V. M. Reddy, S. Thelitz, Y.-P. He, D. M. McMullan, F. L. Hanley, and R. K. Riemer The role of oxidative stress in the development of pulmonary arteriovenous malformations after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Chu, Q. Y. Wu, and W. M. Wang Pulmonary Blood Distribution After Total Cavopulmonary Connection Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 282 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Malhotra, R. K. Riemer, S. Thelitz, Y.-P. He, F. L. Hanley, and V. M. Reddy Superior cavopulmonary anastomosis suppresses the activity and expression of pulmonary angiotensin-converting enzyme J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 464 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Starnes, B. W. Duncan, J. M. Kneebone, G. L. Rosenthal, K. Patterson, C. H. Fraga, K. M. Kilian, S. K. Mathur, and F. M. Lupinetti Angiogenic proteins in the lungs of children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 518 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Starnes, B. W. Duncan, J. M. Kneebone, C. H. Fraga, S. States, G. L. Rosenthal, and F. M. Lupinetti Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 902 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Walker, T. T. Howe, R. L. Davies, J. Fisher, and K. G. Watterson Distribution of hepatic venous blood in the total cavo-pulmonary connection: an in vitro study Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 658 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J KROWKA Hepatopulmonary syndromes Gut, January 1, 2000; 46(1): 1 - 4. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |